SHENZHEN YAFEI TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN YAFEI TECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TERUBIN and WSHEWIT. The owner is based in SHENZHEN.
NO.1,EAST FOURTH LANE,YONGXING STREET,
MASHANTOU COMMUNITY, GONGMING STREET,GUANGMING, NEW DISTRICT,
SHENZHEN , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN YAFEI TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SHENZHEN YAFEI TECHNOLOGY CO., LTD. have?
SHENZHEN YAFEI TECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does SHENZHEN YAFEI TECHNOLOGY CO., LTD. file in?
SHENZHEN YAFEI TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SHENZHEN YAFEI TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN YAFEI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as TERUBIN and WSHEWIT. These are among 2 currently registered trademarks in the portfolio.
What is SHENZHEN YAFEI TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN YAFEI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.